Free Trial

Calumet Specialty Products Partners (NASDAQ:CLMT) Sees Strong Trading Volume on Analyst Upgrade

Calumet Specialty Products Partners logo with Oils/Energy background

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) shares saw strong trading volume on Monday after Wells Fargo & Company raised their price target on the stock from $25.00 to $29.00. Wells Fargo & Company currently has an overweight rating on the stock. 165,373 shares were traded during mid-day trading, a decline of 54% from the previous session's volume of 362,593 shares.The stock last traded at $21.34 and had previously closed at $20.06.

CLMT has been the subject of several other reports. StockNews.com started coverage on Calumet Specialty Products Partners in a research report on Tuesday, October 15th. They set a "hold" rating for the company. TD Cowen lifted their price objective on Calumet Specialty Products Partners from $22.00 to $27.00 and gave the stock a "buy" rating in a research note on Thursday. The Goldman Sachs Group decreased their target price on shares of Calumet Specialty Products Partners from $17.00 to $15.00 and set a "buy" rating for the company in a research report on Monday, August 5th. Finally, HC Wainwright restated a "buy" rating and set a $25.00 price target on shares of Calumet Specialty Products Partners in a report on Thursday. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $24.00.

View Our Latest Report on CLMT

Institutional Investors Weigh In On Calumet Specialty Products Partners

Several large investors have recently added to or reduced their stakes in CLMT. Future Financial Wealth Managment LLC bought a new position in shares of Calumet Specialty Products Partners during the 1st quarter worth approximately $119,000. Deuterium Capital Management LLC acquired a new stake in Calumet Specialty Products Partners in the first quarter worth $159,000. Wedbush Securities Inc. acquired a new position in shares of Calumet Specialty Products Partners during the second quarter valued at about $169,000. Mcintyre Freedman & Flynn Investment Advisers Inc. acquired a new position in shares of Calumet Specialty Products Partners during the first quarter valued at about $171,000. Finally, Sapient Capital LLC boosted its position in shares of Calumet Specialty Products Partners by 9.5% during the 2nd quarter. Sapient Capital LLC now owns 11,501 shares of the oil and gas company's stock worth $185,000 after purchasing an additional 1,000 shares in the last quarter. Institutional investors and hedge funds own 34.41% of the company's stock.

Calumet Specialty Products Partners Stock Performance

The company has a 50 day moving average price of $18.31 and a 200 day moving average price of $16.37. The company has a market capitalization of $1.70 billion, a price-to-earnings ratio of -302.14 and a beta of 1.92.

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last announced its quarterly earnings data on Friday, August 9th. The oil and gas company reported ($0.48) EPS for the quarter, beating analysts' consensus estimates of ($0.55) by $0.07. The firm had revenue of $1.13 billion during the quarter, compared to analyst estimates of $889.17 million. During the same period last year, the business posted ($0.19) EPS. The company's revenue was up 11.4% on a year-over-year basis. Research analysts forecast that Calumet Specialty Products Partners, L.P. will post -1.97 EPS for the current year.

About Calumet Specialty Products Partners

(Get Free Report)

Calumet, Inc manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Montana/Renewables; and Performance brands segments.

Featured Articles

→ Watch this before it gets removed (From Porter & Company) (Ad)

Should you invest $1,000 in Calumet Specialty Products Partners right now?

Before you consider Calumet Specialty Products Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.

While Calumet Specialty Products Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?
Build-to-Order: The Strategy Fueling Toll Brothers’ Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines